Search Results - "Remme, W. J."

Guidelines for the diagnosis and treatment of chronic heart failure by Remme, W. J., Swedberg, K.

Get full text

The sympathetic nervous system and ischaemic heart disease by REMME, W. J

“…The sympathetic nervous system, coronary artery disease and myocardial ischaemia are related in different ways. First, the sympathetic system may be involved…”
Get full text

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure by Pitt, Bertram, Zannad, Faiez, Remme, Willem J, Cody, Robert, Castaigne, Alain, Perez, Alfonso, Palensky, Jolie, Wittes, Janet

“…Aldosterone has an important role in the pathophysiology of heart failure. 1 – 4 Aldosterone promotes the retention of sodium, the loss of magnesium and…”
Get full text

ACE inhibition and endothelial function : Main findings of PERFECT, a sub-study of the EUROPA trial by BOTS, M. L, REMME, W. J, LIISCHER, T. F, FOX, K. M, BERTRAND, M, FERRARI, R, SIMOONS, M. L, GROBBEE, D. E

“…ACE inhibition results in secondary prevention of coronary artery disease (CAD) through different mechanisms including improvement of endothelial dysfunction…”
Get full text

Pharmacological modulation of cardiovascular remodeling: A guide to heart failure therapy by REMME, W. J

“…Cardiac remodeling is a complex process, which involves genetic, molecular and cellular changes in cardiomyocytes and the interstitium, leading to progressive…”
Get full text

Beta-blocking agents in heart failure Should they be used and how? by Cleland, J. G. F., Bristow, M. R., Erdmann, E., Remme, W. J., Swedberg, K., Waagstein, F.

“…Experience accumulated from several large trials strongly suggests that beta-blockers should be used for the management of chronic heart failure[87]. It is…”
Get full text

The european trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA) by FOX, K. M, HENDERSON, J. R, BERTRAND, M. E, FERRARI, R, REMME, W. J, SIMOONS, M. L

“…Angiotensin-converting enzyme (ACE) inhibitors have an accepted place in the treatment of hypertension and heart failure. However, at present they have no…”
Get full text

Drug-induced heart failure by Feenstra, Johannes, Grobbee, Diederick E, Remme, Willem J, Stricker, Bruno H.Ch

“…Heart failure is a clinical syndrome that is predominantly caused by cardiovascular disorders such as coronary heart disease and hypertension. However, several…”
Get full text

Towards the better treatment of heart failure by REMME, W. J

“…During recent decades, heart failure has become one of, if not the, most important syndrome(s) in the cardiovascular area in terms of prevalence, morbidity,…”
Get full text

Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial by Lubsen, J., Just, H., Hjalmarsson, A. C., La Framboise, D., Remme, W. J., Heinrich-Nols, J., Dumont, J. M., Seed, P.

“…PRIMARY OBJECTIVE: To determine the effects of pimobendan 2.5 and 5 mg daily on exercise capacity in patients with chronic heart failure. DESIGN: A randomised,…”
Get full text

Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy? by Remme, W J

“…In addition to being accepted therapy in hypertension and heart failure, ACE inhibitors may well offer a new dimension in anti-ischaemic therapy. Currently,…”
Get full text

Effect of ACE inhibition on neurohormones by REMME, W. J

“…Long-term controlled trials in heart failure in patients with asymptomatic left ventricular dysfunction indicate the potential of ACE inhibition to reduce…”
Get full text

Prevention of worsening heart failure : future focus by REMME, W. J

“…For decades heart failure therapy has focused on symptomatic treatment, whereas preventive aspects have received less attention. However, 10 years of large…”
Get full text

Feedback Regulation of Angiotensin Converting Enzyme Activity and mRNA Levels by Angiotensin II by Schunkert, Heribert, Ingelfinger, Julie R, Hirsch, Alan T, Pinto, Yigal, Remme, Willem J, Jacob, Howard, Dzau, Victor J

“…Although renin and angiotensinogen are known to be subject to feedback regulation, the effects of angiotensin II (Ang II) on the regulation of angiotensin…”
Get full text

Overview of the relationship between ischemia and congestive heart failure by Remme, Willem J.

“…Ischemic heart disease is the principal etiology of heart failure in the Western world. Myocardial ischemia is important in cardiac remodeling, a process that…”
Get full text

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) by Fox, K M

“…Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces the rate of cardiovascular events among patients with left-ventricular dysfunction and…”
Get full text

Treatment of congestive heart failure. Has the time come for decreased complexity? by Rydén, L., Remme, W.J.

Get full text

Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival by Simoons, Maarten L., Serruys, Patrick W., van den Brand, Marcel, Res, Jan, Verheugt, Freek W.A., Krauss, X. Hanno, Remme, Willem J., Bär, Frits, Zwaan, Chris de, Laarse, Arnoud van der, Vermeer, Frank, Lubsen, Jacobus

“…The effect of thrombolysis in acute myocardial infarction on infarct size, left ventricular function, clinical course and patient survival was studied in a…”
Get full text

Therapeutic strategies and neurohormonal control in heart failure by Remme, W J

“…Neurohormonal activation is one of the major determining factors in the process of transition from asymptomatic ventricular dysfunction to end-stage heart…”
Get more information

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial by Metra, Marco, Torp-Pedersen, Christian, Swedberg, Karl, Cleland, John G.F., Di Lenarda, Andrea, Komajda, Michel, Remme, Willem J., Lutiger, Beatrix, Scherhag, Armin, Lukas, Mary Ann, Charlesworth, Andrew, Poole-Wilson, Philip A.

“…Aims We studied the influence of heart rate (HR), systolic blood pressure (SBP), and beta-blocker dose on outcome in the 2599 out of 3029 patients in…”
Get full text